<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The expression of interleukin-2 receptors (IL-2R) was examined in 328 adult patients with non-T-cell (non-T) <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> of <z:hpo ids='HP_0011010'>chronic</z:hpo> myelocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:mp ids='MP_0005481'>CML</z:mp>.BC) using two monoclonal antibodies, anti-Tac for IL-2R alpha chain (IL-2R alpha) and Mik beta 1 for IL-2R beta chain (IL-2R beta) </plain></SENT>
<SENT sid="1" pm="."><plain>Leukaemic cells in the following cases were positive for anti-Tac; 28/192 of <z:hpo ids='HP_0011009'>acute</z:hpo> myelocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), 24/44 <z:mp ids='MP_0005481'>CML</z:mp>-BC, 4/28 CD19(+)CD10(-) <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (ALL), and 20/64 common ALL (<z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">c-ALL</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>IL-2R beta was not detected on leukaemic cells of any case examined </plain></SENT>
<SENT sid="3" pm="."><plain>Eleven of IL-2R alpha(+) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> were derived from <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>None of the IL-2R alpha positive leukaemic cells responded to exogenous recombinant human IL-2 (rhIL-2) in culture </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, IL-2R alpha expression on non-T leukaemic cells was closely correlated with coexpressing different lineage markers and the presence of the Philadelphia abnormality </plain></SENT>
<SENT sid="6" pm="."><plain>Marked increase of serum soluble IL-2R alpha was demonstrated in the IL-2R alpha(+) patients examined </plain></SENT>
<SENT sid="7" pm="."><plain>Clinically, the IL-2R alpha(+) patients showed significantly lower response to chemotherapy and poorer prognosis than IL-2R alpha(-) patients </plain></SENT>
<SENT sid="8" pm="."><plain>Our results clearly indicate the diagnostic importance of IL-2R alpha expression in non-T <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> with a close relation to the particular cellular characteristics and the prognosis </plain></SENT>
</text></document>